MedTrace Logo

Effects of Percutaneous Electrical Stimulation in Patients With Chronic Supraspinatus Tendinopathy

NCT07498569 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2026-03-27

No results posted yet for this study

Summary

The aim of this clinical trial is to evaluate the effects of two percutaneous stimulation techniques-Percutaneous Electrical Stimulation (PENS) and Percutaneous Electrolysis (PE)-combined with a therapeutic exercise (TE) program for the shoulder joint complex, on pain and function in individuals with chronic supraspinatus tendinopathy.

The main question this study seeks to answer is: Would incorporating percutaneous electrical stimulation (PENS) of the axillary and suprascapular nerves and galvanic percutaneous stimulation (PE) of the supraspinatus tendon into a therapeutic exercise (TE) program for the shoulder joint complex improve therapeutic outcomes in terms of pain, function, and upper limb disability? Based on an exercise program in all groups, researchers will compare the efficacy of active PENS and PE, as well as placebo, in all their combinations.

Participants will undergo a 12-week exercise program, during which they will receive four sessions (one session per week) of active percutaneous electrical stimulation or a placebo during the first month.

Participants will:

* Visit the center on four separate occasions for results measurement.
* Keep a session log to verify adherence to the exercise program.

Conditions

  • Supraspinatus Tendinopathy

Interventions

PROCEDURE

EP + PENS + ET

Percutaneous Electrolysis (EP) + Percutaneous Electrical Nerve Stimulation (PENS) + Therapeutic Exercise (ET)

PROCEDURE

EP + PENS placebo + ET

Percutaneous Electrolysis (PE) + Percutaneous Electrical Nerve Stimulation (PENS - placebo) + Therapeutic Exercise (ET)

PROCEDURE

EP placebo + PENS + ET

Percutaneous Electrolysis (EP - placebo) + Percutaneous Electrical Nerve Stimulation (PENS) + Therapeutic Exercise (ET)

PROCEDURE

EP placebo + PENS placebo + ET

Percutaneous Electrolysis (EP - placebo) + Percutaneous Electrical Nerve Stimulation (PENS - placebo) + Therapeutic Exercise (ET)

Sponsors & Collaborators

  • Universidad Miguel Hernandez de Elche

    lead OTHER

Principal Investigators

  • José-Vicente Toledo-Marhuenda, Ph D · Miguel Hernández University. Faculty of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2027-06-01
Completion
2027-06-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07498569 on ClinicalTrials.gov